hepat
c
viru
hcv
caus
seriou
liver
diseas
includ
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
hcv
infect
manifest
mainli
human
liver
hepatocyt
hematopoiet
cell
strict
tropism
hcv
infect
depend
two
major
factor
abil
hcv
enter
target
cell
permiss
hcv
replic
insid
cell
target
cell
access
mediat
hcv
receptor
coreceptor
identifi
use
hcv
cell
cultur
system
scaveng
receptor
class
b
member
srbi
lowdens
lipoprotein
receptor
ldlr
occludin
ocln
although
ocln
essenti
determin
tropism
hcv
infect
human
cellular
protein
ubiquit
express
human
tissu
respons
hepatotrop
hcv
infect
one
liverspecif
molecul
may
influenc
access
cell
pathogen
ctype
lectin
domain
famili
member
also
known
lsign
dcsignr
highli
express
liver
sinusoid
endotheli
cell
hepatocyt
dendrit
cell
soilleux
colleagu
identifi
cdna
sequenc
gene
relat
dendriticcellspecif
nonintegrin
dcsign
ctermin
end
possess
carbohydraterecognit
domain
bind
mannos
oligosaccharid
present
envelop
pathogen
act
captur
receptor
virus
pathogen
includ
human
immunodefici
viru
type
ebola
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
tuberculosi
previous
report
mediat
transinfect
hcvpp
pseudoparticl
use
cell
captur
artifici
hcvpp
transmit
hepatocyt
howev
unknown
whether
act
receptor
hcvcc
cellcultureproduc
hcv
transinfect
whether
bind
receptor
entri
receptor
hcvcc
cell
compet
hcv
rna
replic
entri
receptor
hcvcc
suscept
hcvcc
infect
cell
bind
receptor
unsuscept
present
studi
use
hcvreplicationpermiss
cell
investig
whether
play
role
liverspecif
hcv
receptor
cisinfect
andor
receptor
transinfect
cell
gift
dr
oshima
nation
institut
infect
diseas
tokyo
japan
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
cell
maintain
complet
medium
contain
invitrogen
carlsbad
ca
per
ml
cell
highli
suscept
hcvcc
infect
cell
gener
dr
oshima
hcv
replicon
cell
cure
interferon
treatment
human
isoform
access
amplifi
human
liver
cdna
use
primer
shown
supplementari
tabl
amplifi
cdna
insert
vector
contain
geneticinresist
gene
invitrogen
nucleotid
sequenc
construct
confirm
correct
cell
transfect
complex
plasmid
dna
lipofectamin
ltx
invitrogen
stabl
clone
transfect
cell
establish
exposur
invitrogen
per
ml
stabl
clone
transfect
vector
use
control
total
rna
extract
cultur
cell
use
trizol
reagent
invitrogen
subject
dnase
treatment
follow
cdna
synthesi
describ
previous
quantiti
mrna
determin
realtim
pcr
use
sybr
green
plasmid
dna
contain
target
gene
use
standard
quantif
hcv
rna
mrna
gene
express
normal
quantiti
gapdh
rel
valu
express
arbitrari
unit
primer
sequenc
design
use
http
shown
supplementari
tabl
cell
seed
cover
slip
incub
overnight
fix
cold
aceton
min
fixat
cell
block
bovin
serum
albumin
phosphatebuff
salin
pb
incub
first
antibodi
mous
antibodi
r
system
inc
minneapoli
mn
andor
dilut
human
serum
hcvposit
donor
human
antihcv
antiserum
use
character
found
reactiv
core
protein
hcvcc
western
blot
lysat
infect
cell
supplementari
fig
cell
stain
secondari
antibodi
conjug
alexafluor
alexafluor
invitrogen
stain
cell
mount
glass
slide
prolong
gold
antifad
reagent
contain
dapi
invitrogen
visual
use
biorevo
microscop
keyenc
osaka
japan
also
use
measur
fluoresc
intens
protein
cell
human
liver
tissu
lyse
use
urea
buffer
urea
thiourea
chap
triton
mm
phenylmethylsulfonyl
fluorid
mm
trishcl
ph
protein
treat
nglycanas
pngase
f
includ
enzymat
protein
deglycosyl
kit
sigmaaldrich
saint
loui
mo
treat
untreat
protein
sampl
electrophores
polyacrylamid
gel
transfer
nitrocellulos
membran
protein
detect
use
goat
antibodi
santa
cruz
biotechnolog
inc
santa
cruz
ca
ng
horseradishperoxidaseconjug
antigoat
igg
zyme
laboratori
san
francisco
ca
per
ml
protein
use
intern
load
standard
detect
use
mous
monoclon
antibodi
abcam
cambridg
uk
horseradishperoxidaseconjug
antimous
igg
ibl
gunma
japan
per
ml
detect
use
ecl
advanc
plu
western
blot
detect
system
ge
healthcar
buckinghamshir
uk
respect
chemiluminesc
detect
lightcaptur
atto
tokyo
japan
analyz
use
cs
analyz
version
softwar
atto
report
replicon
rna
transcrib
vitro
plasmid
introduc
cell
transfect
describ
previous
luciferas
activ
determin
use
luciferas
assay
system
promega
madison
wi
infinit
micropl
reader
tecan
switzerland
hcvcc
deriv
prepar
describ
previous
produc
larg
amount
hcvcc
cell
inocul
hcvcc
hcv
rna
copiesml
h
cultur
ml
complet
medium
cultur
supernat
collect
day
postinfect
pass
filter
filter
supernat
store
use
infecti
titer
hcvcc
focusform
unit
ffu
per
ml
rna
titer
copi
hcv
rnaml
cell
seed
coverslip
plate
incub
overnight
cell
incub
hcvcc
h
cultur
complet
medium
day
postinfect
infect
cell
detect
immunofluoresc
stain
hcv
protein
infect
foci
count
use
fluoresc
microscopi
olympu
tokyo
japan
assay
perform
triplic
cell
seed
cell
per
well
plate
cell
inocul
h
later
hcvcc
h
wash
five
time
wash
buffer
mm
trishcl
ph
mm
nacl
mm
mm
bovin
serum
albumin
wash
remov
unbound
hcvcc
cell
complet
medium
ad
cell
cocultur
h
day
total
rna
extract
cocultur
cell
quantiti
hcv
rna
determin
cocultur
cell
cover
slip
also
stain
hcv
protein
immunofluoresc
stain
transinfect
inhibit
assay
cell
preincub
complet
medium
contain
min
follow
infect
hcvcc
specif
recogn
carbohydraterecognit
domain
assay
perform
triplic
student
ttest
mannwhitney
u
test
use
analyz
data
pvalu
less
consid
statist
signific
investig
potenti
receptor
role
hcv
infect
produc
cell
use
cell
clone
cell
clone
highli
permiss
hcv
replic
suscept
hcv
infect
cell
clone
neg
howev
except
express
level
hcv
receptor
gene
cell
clone
similar
hcv
permiss
cell
supplementari
fig
sinc
also
neg
mrna
establish
cell
use
cell
produc
high
level
mrna
protein
fig
western
blot
analysi
protein
show
multipl
band
differ
size
kda
cell
human
liver
convert
singl
band
kda
treatment
nglycanas
fig
thu
glycosyl
pattern
differ
cell
human
liver
similar
neg
control
cell
clone
also
cell
establish
transfect
cell
transform
hcvsuscept
cell
fig
thu
cell
clone
use
determin
whether
entri
receptor
hcvcc
take
place
examin
whether
act
receptor
cisinfect
cell
inocul
hcvcc
ffu
six
day
hcv
infect
none
nc
cell
posit
hcv
contrast
cell
posit
hcv
fig
thu
entri
receptor
hcv
substitut
mediat
hcv
cisinfect
next
investig
whether
involv
transinfect
hcvcc
four
hour
inocul
hcvcc
amount
hcv
rna
cell
cell
fig
amount
attach
hcvcc
similar
nc
cell
howev
level
hcv
rna
day
cultiv
increas
cell
cocultur
cell
comparison
neg
control
fig
shown
immunofluoresc
stain
hcv
day
cocultur
hcvposit
cell
adjac
cell
fig
confirm
transinfect
cell
treat
antibodi
inocul
hcvcc
amount
hcv
rna
decreas
specif
treatment
antibodi
fig
case
cell
cell
result
suggest
receptor
hcv
transinfect
studi
show
inact
vitro
cisinfect
activ
transinfect
hcvcc
transinfect
mediat
carbohydraterecognit
domain
directli
proven
first
time
use
infecti
hcvcc
particular
host
cell
permiss
hcv
rna
replic
neg
posit
directli
show
serv
endocytot
receptor
hcv
infecti
particl
helper
hcv
endocytosi
place
dcsign
analog
protein
function
endocytot
receptor
intern
motif
triacid
cluster
dileucin
motif
tyrosinebas
motif
intracellular
ntermin
domain
triacid
cluster
dileucin
motif
present
ntermin
region
tyrosinebas
motif
absent
howev
jurkat
cell
suscept
ebola
viru
cisinfect
cho
cell
captur
sarscov
incorpor
lead
proteasomedepend
viral
degrad
cell
intern
hcv
viruslik
particl
consist
recombin
envelop
protein
differ
hcvpp
thu
intern
cell
depend
type
cell
ligand
earli
stage
infect
attach
entri
hcv
requir
particular
cooper
multipl
receptor
includ
coreceptor
interact
activ
receptor
hcv
might
defici
cell
clarifi
physiolog
relev
hcv
tropism
necessari
examin
human
liver
sinusoid
cell
lsec
ci
transinfect
hcvcc
although
demonstr
human
liver
differ
glycosyl
pattern
cell
fig
ludwig
cowork
show
hcv
viruslik
particl
bound
lsec
human
liver
tissu
section
situ
thu
differ
glycosyl
pattern
lsec
may
affect
attach
hcv
lai
colleagu
demonstr
express
human
lsec
function
bind
hcv
glycoprotein
primari
human
lsec
support
hcvpp
entri
thu
lsec
entri
receptor
hcv
therefor
lsec
resist
hcvcc
infect
lsec
inde
found
resist
hcvcc
cocultur
cell
still
unknown
whether
lsec
permiss
hcv
replic
recent
fletcher
associ
show
lsec
infect
hcvpp
express
srbi
cell
low
found
human
brain
endotheli
cell
express
function
receptor
support
entri
replic
hcvcc
result
suggest
lsec
unsuscept
hcv
infect
due
lower
abund
coreceptor
cell
lsec
possibl
function
mediat
transinfect
hcv
sever
investig
shown
mediat
transinfect
hcvpp
show
present
studi
actual
mediat
transinfect
bona
fide
hcvcc
howev
attach
hcvcc
cell
appar
similar
fig
nonspecif
bind
may
respons
attach
cell
qualit
differ
cell
nonspecif
bind
probabl
weak
mediat
transinfect
hcvcc
adjac
cell
lack
intern
case
indic
transinfect
might
occur
releas
captur
hcvcc
adjac
hepatocyt
case
human
liver
vivo
transinfect
mediat
lsec
occur
without
intern
duck
liver
vivo
duck
hepat
b
viru
captur
lsec
intern
lsec
transfer
adjac
hepatocyt
also
incorpor
dendrit
cell
dcsign
transmit
cell
via
exosom
thu
virus
temporarili
pool
reservoir
cell
escap
host
immun
evas
still
unknown
whether
human
lsec
intern
hcv
whether
human
lsec
permiss
hcv
rna
replic
conclus
demonstr
captur
receptor
hcvcc
substitut
entri
receptor
therefor
mediat
cisinfect
mediat
transinfect
without
intern
hcvcc
find
other
suggest
lsec
respons
hepatotrop
hcv
infect
captur
releas
hcv
adjac
hepatocyt
serv
receptor
hcv
cisinfect
